Custom Polysaccharide Synthesis
Overview
Due to the complex structure and the microscopic inhomogeneity of polysaccharides, the synthesis of polysaccharides has long plagued synthetic chemists. CD BioGlyco can provide customers with a custom one-stop polysaccharide synthesis service, According to their research needs, customers can obtain different types and modified polysaccharides. We have confidence to be your essential research assistant in the field of glycobiology.
Key Technologies
Advanced Glycosylation Methods
We utilize highly efficient strategies, including thioglycoside, O-glycoside, and N-pentenyl glycoside donors, to achieve high yields and stereoselectivity. Our methods are optimized for both α- and β-linkages, allowing for precise control over the anomeric configuration, which is critical for natural polysaccharide structures.
Strategic Protecting Group Manipulations
The multi-hydroxyl nature of monosaccharides necessitates careful protecting group strategies to control reactivity and enable selective glycosylation. CD BioGlyco employs a sophisticated toolkit of orthogonal protecting groups (e.g., benzyl, acetyl, pivaloyl, silyl ethers) and leverages modern protecting group manipulations, including photolabile protecting groups, to facilitate efficient and convergent synthesis strategies, especially for highly branched or complex architectures.
Convergent Assembly Strategies
For the synthesis of large and complex polysaccharides, we primarily employ convergent strategies. This involves synthesizing smaller, well-defined oligosaccharide blocks or fragments, which are then coupled together in a highly efficient manner. This modular approach significantly reduces the number of steps and improves overall yields, allowing for the construction of very long polysaccharide chains (e.g., beyond 20 monosaccharide units, and even ultra-long glycans like 92-mer, 100-mer, or 151-mer chains).
Automated Synthesis Platforms
To enhance reproducibility, throughput, and efficiency, we integrate automated solid-phase synthesis techniques where applicable. This technology streamlines the iterative addition of monosaccharide units and simplifies purification, accelerating the delivery of custom polysaccharides.
Background
Polysaccharides are the most abundant biopolymers on earth. They can perform various structural and regulatory functions. Their biological activity depends on the chemical structure, including the composition of monosaccharides, linkages below sugar residues, and the solution conformation. In contrast to polypeptides and polynucleotides, polysaccharides are branched, and each glycosidic bond can form a new stereocenter, which allows only a few monosaccharides to form a variety of different polymers. The construction of polysaccharides through chemical, enzymatic or chemoenzymatic synthesis requires stereo and regional control at each step. For carbohydrates separated as heterogeneous mixtures, synthesis still faces difficulties in detailed molecular understanding.
Due to the important biological functions of polysaccharides, learning the comprehensive definition of their linearity and branching is essential. Many researchers have reported that the chemical modification of polysaccharides significantly increases the diversity of structures, improves biological activity, and even adds new biological activities, including antioxidant and anti-tumor properties, as well as anticoagulant and immunomodulatory activities.

Unlock the Sugar Code: Synthesized for Science
- We synthesize diverse polysaccharide architectures, including linear chains and complex branched structures with specific linkage patterns and terminal modifications.
- From shorter oligosaccharides to ultra-long polysaccharide chains containing dozens or even hundreds of monosaccharide units, our methods are adaptable to varying length requirements.
- Our expertise allows for the integration of unusual or non-natural monosaccharide residues into the polysaccharide backbone, expanding the functional possibilities of the synthesized glycans.
- For advanced mechanistic studies or nuclear magnetic resonance (NMR) investigations, we synthesize isotopically labeled polysaccharides, providing invaluable tools for detailed structural and dynamic analyses.
- Our customized modifications include sulfation, phosphorylation, carboxymethylation, selenization, methylation, acetylation, and other chemical modifications. And many polysaccharides with different labels, such as biotin, fluorescein, and rhodamine, etc.
Workflow
Monomer and Building Block Synthesis
We synthesize or acquire the necessary monosaccharide building blocks, ensuring they are appropriately functionalized and protected for subsequent glycosylation reactions. For complex or rare structures, custom synthesis of these precursors is performed.
Fragment Assembly
For longer polysaccharides, we proceed with the convergent synthesis of smaller oligosaccharide fragments. This involves iterative glycosylation reactions, followed by deprotection and purification steps, to generate well-defined, activated oligosaccharide blocks.
Polysaccharide Elongation and Coupling
The prepared oligosaccharide fragments are then coupled together using highly efficient glycosylation methods to build the desired polysaccharide chain. This step is carefully optimized for maximum yield and minimal side reactions, especially for forming ultra-long glycans.
Deprotection, Purification, and Characterization
Once the full polysaccharide chain is assembled, all temporary protecting groups are selectively removed. The crude product undergoes rigorous purification using advanced chromatographic techniques (e.g., size-exclusion chromatography) to achieve the required purity. Finally, the synthesized polysaccharide is comprehensively characterized using techniques such as mass spectrometry to confirm its exact structure, molecular weight, and purity.

Publication Data
DOI.: 10.1021/jacs.0c00751
Journal: Journal of the American Chemical Society
IF: 15.6
Published: 2020
Results: This study achieves a breakthrough in automated polysaccharide synthesis through optimized automated glycan assembly (AGA) on solid phase, enabling unprecedented chain lengths. The authors synthesized a linear 100-mer α-(1→6)-polymannoside via iterative AGA cycles with high stepwise yield (98.75%), alongside a branched 151-mer polymannoside assembled through convergent coupling of AGA-prepared segments—a branched 31-mer acceptor and four 30-mer glycosyl fluoride donors. Critical to this success was the implementation of capping steps to suppress deletion sequences, utilization of a photocleavable linker for efficient product release, employment of AgClO4-activated glycosyl fluoride donors for efficient block couplings, and rigorous real-time high-performance liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (HPLC/MALDI-MS) monitoring. Collectively, these advances provide rapid access to structurally defined, ultra-long polysaccharides—previously inaccessible via traditional methods—for probing glycan functions and developing carbohydrate-based materials.
Advantages
- Our chemical synthesis methodologies provide absolute control over glycosidic bond formation, anomeric configuration, and branching patterns, ensuring the delivery of homogeneous, structurally defined polysaccharides that are impossible to isolate from natural sources.
- Leveraging cutting-edge convergent strategies and efficient glycosylation methods, we possess the unique capability to synthesize not only complex but also remarkably long polysaccharide chains, including those exceeding 100 monosaccharide units, enabling studies on large polymeric glycans.
- Our robust synthetic platform allows for the incorporation of a broad spectrum of natural and non-natural monosaccharides, offering unparalleled flexibility in designing and creating novel polysaccharide structures with specific biological or material properties.
Applications
- Polysaccharides and their derivatives hold immense promise as therapeutic agents (e.g., anticoagulants, anti-inflammatories, antivirals) and drug delivery vehicles.
- Polysaccharides play a key role in tissue engineering, regenerative medicine, and drug delivery systems, where their excellent biocompatibility and biodegradability make them ideal materials for developing hydrogels, scaffolds, and coatings.
- Understanding and manipulating the structure of dietary polysaccharides is important for researching functional foods and nutraceuticals with beneficial effects on gut health, immunity, and metabolic regulation.
Associated Services

Custom polysaccharide synthesis provides the essential foundation of precisely engineered carbohydrate polymers. This capability directly enables our Polysaccharide-modified Nanoparticle Production Service, where these tailored polysaccharides are strategically employed to functionalize nanoparticle surfaces, enhancing biocompatibility, targeting, and stability for advanced biomedical and research applications. Furthermore, the versatility of synthetic polysaccharides extends powerfully into material science, underpinning the development of Polysaccharide-based Biodegradable Material for Food Packaging. Here, polysaccharides like chitosan or customized derivatives offer sustainable, non-toxic barrier properties crucial for modern eco-friendly packaging solutions. Finally, the rigorous application of polysaccharide characterization and immunogenicity assessment techniques, core to our synthesis expertise, is vital for our Group A Meningococcal Polysaccharide Vaccine Evaluation Service. This service leverages deep polysaccharide knowledge to critically assess vaccine purity, molecular size, identity, and crucially, immunological potency for safety and efficacy confirmation. Thus, custom synthesis serves as the cornerstone for diverse, high-impact applications spanning nanotechnology, sustainable materials, and life-saving vaccine development.
Frequently Asked Questions
CD BioGlyco has numerous successful experiences in the custom synthesis of polysaccharides. Our well-trained researchers and the most advanced facilities can provide customers with higher-quality synthesis services to help customers explore polysaccharides faster and more comprehensively.
Customers can contact our employees directly and we will respond promptly. If you are interested in our services, please contact us for more detailed information.
Reference
- Joseph, A.A.; et al. Total synthesis of polysaccharides by automated glycan assembly. Journal of the American Chemical Society. 2020, 142(19): 8561-8564. (CCBY)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




